FindTrial
Sign In

Prospective randomized controlled trial of perioperative antibiotic prophylaxis in patients with hepatocellular carcinoma undergoing hepatic resection

Prospective randomized controlled trial of perioperative antibiotic prophylaxis in patients with hepatocellular carcinoma undergoing hepatic resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-POR-15006604
Enrollment
Unknown
Registered
2015-06-15
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

1:antibiotic prophylaxis for 24 hours
2:antibiotic prophylaxis for 72 hours

Sponsors

Department of general surgery, West China Hospital of Sichuan University, Chengdu (610041), China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients with hepatocellular carcinoma; 2. adult patients, all genders; 3. voluntary; 4. patients only underwent hepatic resection (including cholecystectomy); 5. patients with good compliance.

Exclusion criteria

Exclusion criteria: 1. patients refuse to participate in this clinical trial; 2. pregnancy or lactating women; 3. patients with poor compliance; 4. patients with any preoperative infection; 5. patients underwent concomitant operations on other organs; 6. patients are allergic to antibiotics applied in this trial.

Design outcomes

Primary

MeasureTime frame
postoperative infective complications;surgical site infection;non-surgical site infection;—

Countries

China

Contacts

Public ContactWen Tian-Fu
tianfu1962@163.com+86 18980601471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026